The State of Business and HIV/AIDS (2006) - Booz Allen Hamilton
The State of Business and HIV/AIDS (2006) - Booz Allen Hamilton
The State of Business and HIV/AIDS (2006) - Booz Allen Hamilton
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
63<br />
How does your organization cooperate with<br />
business associates <strong>and</strong> suppliers to address<br />
<strong>HIV</strong>/<strong>AIDS</strong>? (check those activities or processes<br />
that match your current company practice)<br />
• No cooperation with business associates <strong>and</strong><br />
suppliers to address <strong>HIV</strong>/<strong>AIDS</strong><br />
• Engage suppliers <strong>and</strong> distributors that comply<br />
with general industry codes<br />
• Integrate <strong>HIV</strong>/<strong>AIDS</strong> compliance into contractual<br />
arrangements with suppliers<br />
• Support implementation <strong>of</strong> <strong>HIV</strong> programs in<br />
supply chain network<br />
• Lead partnership with other companies <strong>and</strong><br />
suppliers grouped by industry/geography for<br />
local <strong>HIV</strong> program roll-out<br />
• Advocate for industry sector policy on <strong>HIV</strong><br />
practices at a global level<br />
CEO Advocacy <strong>and</strong> Leadership<br />
<strong>The</strong> voice <strong>of</strong> business leaders can promote<br />
change <strong>and</strong> influence <strong>HIV</strong>/<strong>AIDS</strong>-related policy.<br />
Within companies, senior management can<br />
address stigma <strong>and</strong> discrimination, send a<br />
clear message on non-discrimination, promote<br />
behaviors that prevent spread <strong>of</strong> the disease; <strong>and</strong><br />
ensure those infected are effectively treated.<br />
What does your organization do to engage<br />
the CEO in <strong>HIV</strong>/<strong>AIDS</strong> programs? (check those<br />
activities or processes that match your current<br />
company practice)<br />
• No public or internal advocacy<br />
• Record Senior Management commitment to<br />
<strong>HIV</strong>/<strong>AIDS</strong> signaled in Annual Report<br />
• Secure CEO communication with employees on<br />
company position on <strong>HIV</strong><br />
• Secure CEO public participation in <strong>AIDS</strong><br />
programs including taking an <strong>HIV</strong> test<br />
• Facilitate Government lobbying <strong>and</strong> donor<br />
mobilization<br />
• Promote international recognition <strong>of</strong> CEO <strong>and</strong><br />
company as a leader on <strong>HIV</strong>/<strong>AIDS</strong><br />
Monitoring, Evaluation <strong>and</strong> Reporting <strong>of</strong> <strong>HIV</strong>/<br />
<strong>AIDS</strong> programs<br />
Companies document <strong>and</strong> record processes<br />
<strong>and</strong> outcomes in order to demonstrate the<br />
effectiveness <strong>of</strong> <strong>HIV</strong>/<strong>AIDS</strong> programs.<br />
Companies have <strong>of</strong>ten developed indicators to<br />
suit their own individual business environment.<br />
Sample indicators include, but are not limited to<br />
utilization by recipient <strong>of</strong> donated products <strong>and</strong><br />
number <strong>of</strong> staff accessing services.